Dolby Laboratories Reports First Quarter Fiscal 2017 Financial Results
Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the first quarter (Q1) of fiscal year
2017. For the first quarter, Dolby reported total revenue of $266.3 million, compared to $240.8 million for the first quarter of
fiscal year 2016.
First quarter GAAP net income was $53.4 million, or $0.51 per diluted share, compared to $30.9 million, or $0.30 per diluted
share, for the first quarter of fiscal 2016. On a non-GAAP basis, first quarter net income was $68.7 million, or $0.66 per diluted
share, compared to $48.6 million, or $0.48 per diluted share, for the first quarter of fiscal 2016. Dolby's non-GAAP measures are
described and reconciled to the corresponding GAAP measures at the end of this release.
"We had a strong first quarter and continue to make progress with Dolby Vision, Dolby Cinema, and Dolby Atmos," said Kevin
Yeaman, President and CEO, Dolby Laboratories. "We announced our first Dolby Vision TV with Sony, and our first combined Dolby
Vision and Dolby Atmos TV with LG. We also opened our 70th Dolby Cinema location."
Dividend
Today, Dolby announced a cash dividend of $0.14 per share of Class A and Class B common stock, payable on February 15, 2017, to
stockholders of record as of the close of business on February 6, 2017.
Stock Repurchase Program
Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $200
million, bringing the amount available for future repurchases of the Company's Class A Common Stock to approximately $227 million.
Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and
in such amounts as the Company considers appropriate.
Financial Outlook
Q2 2017
Dolby estimates that total revenue for the second quarter (Q2) of fiscal 2017 will range from $265 million to $280 million.
Gross margin percentages are projected to range between 88 percent and 89 percent on a GAAP basis, and between 89 percent and 90
percent on a non-GAAP basis.
Dolby anticipates that operating expenses will be between $177 million and $181 million on a GAAP basis, and between $158
million and $162 million on a non-GAAP basis.
Dolby estimates that diluted earnings per share will be between $0.43 and $0.49 on a GAAP basis, and between $0.58 and $0.64 on
a non-GAAP basis.
Dolby estimates that its fiscal Q2 2017 effective tax rate will be between 24 percent and 25 percent on both a GAAP and non-GAAP
basis.
Fiscal Year 2017
Dolby anticipates that total revenue will range from $1.06 billion to $1.10 billion.
Dolby anticipates that operating expenses will range from $700 million to $710 million on a GAAP basis, and from $625 million to
$635 million on a non-GAAP basis.
Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss Q1 fiscal 2017 financial
results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, January 25, 2017. Access to the teleconference will be
available over the Internet from http://investor.dolby.com/events.cfm or by dialing 1-877-718-5104. International
callers can access the conference call at 1-719-325-4895.
A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Wednesday, January 25, 2017, until 8:59 p.m. PT
(11:59 p.m. ET) on Wednesday, February 1, 2017, by dialing 1-844-512-2921 (international callers can access the replay by dialing
1-412-317-6671) and entering the confirmation code 5454615. An archived version of the teleconference will also be available on the
Dolby Laboratories website, http://investor.dolby.com/events.cfm.
Non-GAAP Financial Information
To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to
provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management
believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our
non-GAAP financial measures:
Stock-based compensation expense. Stock-based compensation, unlike cash-based compensation, utilizes subjective and
complex assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may
differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and
those of other companies, we exclude stock-based compensation expense.
Expense associated with dividend equivalents paid on restricted stock units. In connection with a special dividend
declared in the first quarter of fiscal 2013, we modified restricted stock units (RSUs) that were unvested at that time to preserve
their pre-cash dividend economic value. The special dividend was a discrete and infrequent event that is not representative of our
normal operating activities; therefore, we exclude the compensation cost related to the dividend equivalents to provide a more
accurate view of our underlying operating results.
Amortization of acquisition-related intangibles. We amortize intangible assets acquired in connection with acquisitions.
These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization
charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from
pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do
not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we
exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating
performance.
Restructuring charges. Restructuring charges are costs associated with a formal restructuring plan and primarily
relate to employee severance benefits and asset impairments. We exclude restructuring costs, including any adjustments to charges
recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore,
excluding these amounts enables a more effective comparison to our past operating performance.
Income tax adjustments. We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments
provides a more accurate view of our underlying operating results to management and investors.
Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP
net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and
non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP
measures in order to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that
investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in
accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial
measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial
measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as
detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and
Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this
press release and on the Dolby Laboratories investor relations website, http://investor.dolby.com.
Forward-Looking Statements
Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial
results for Q2 2017 and fiscal 2017, our ability to advance our long-term objectives, and future dividend payments and stock
repurchases are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are
based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ
materially from those projected. The following important factors, without limitation, could cause actual results to differ
materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates,
including the broadcast, PC, Consumer Electronics, Cinema and other markets; the loss of, or reduction in sales by, a key customer
or licensee; pricing pressures; risks associated with the rate at which OEMs include optical disc playback in Windows®
devices and the rate of consumer adoption of Windows operating systems; risks that a shift from disc-based media to online media
content could result in fewer devices with Dolby® technologies; risks associated with the effects of macroeconomic
conditions, including trends in consumer spending; risks relating to the expiration of patents; the timing of Dolby's receipt of
royalty reports and payments from its licensees, including back payments; timing of revenue recognition under licensing agreements
and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants;
Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks
associated with conducting business in China and other countries that have historically limited recognition and enforcement of
intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's
ability to increase its revenue streams and expand its business generally, and to expand its business beyond audio technologies to
other technologies; risks associated with acquiring and successfully integrating businesses or technologies; and other risks
detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its most
recent annual report on Form 10-K. Dolby disclaims any obligation to update information contained in these forward-looking
statements whether as a result of new information, future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE:DLB) creates audio, video, and voice technologies that transform entertainment and communications in
mobile devices, at the cinema, at home, and at work. For more than 50 years, sight and sound experiences have become more vibrant,
clear, and powerful in Dolby. For more information, please visit www.dolby.com.
Dolby, Dolby Atmos, and the double-D symbol are registered trademarks of Dolby Laboratories. Dolby Cinema and Dolby Vision are
trademarks of Dolby Laboratories. All other trademarks remain the property of their respective owners. DLB-F
|
|
|
|
DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
|
|
|
|
|
|
Fiscal Quarter Ended |
|
|
December 30,
2016 |
|
January 1,
2016 |
| Revenue: |
|
(unaudited) |
|
(unaudited) |
| Licensing |
|
$ |
232,699 |
|
|
$ |
211,129 |
|
| Products |
|
28,211 |
|
|
24,809 |
|
| Services |
|
5,357 |
|
|
4,876 |
|
| Total revenue |
|
266,267 |
|
|
240,814 |
|
|
|
|
|
|
| Cost of revenue: |
|
|
|
|
| Cost of licensing |
|
8,121 |
|
|
6,533 |
|
| Cost of products |
|
17,720 |
|
|
19,038 |
|
| Cost of services |
|
4,126 |
|
|
4,195 |
|
| Total cost of revenue |
|
29,967 |
|
|
29,766 |
|
|
|
|
|
|
| Gross margin |
|
236,300 |
|
|
211,048 |
|
|
|
|
|
|
| Operating expenses: |
|
|
|
|
| Research and development |
|
57,518 |
|
|
53,328 |
|
| Sales and marketing |
|
71,175 |
|
|
74,454 |
|
| General and administrative |
|
41,540 |
|
|
44,078 |
|
| Total operating expenses |
|
170,233 |
|
|
171,860 |
|
|
|
|
|
|
| Operating income |
|
66,067 |
|
|
39,188 |
|
|
|
|
|
|
| Other income/expense: |
|
|
|
|
| Interest income |
|
1,814 |
|
|
1,297 |
|
| Interest expense |
|
(26 |
) |
|
(29 |
) |
| Other income/(expense), net |
|
(199 |
) |
|
(972 |
) |
| Total other income |
|
1,589 |
|
|
296 |
|
|
|
|
|
|
| Income before income taxes |
|
67,656 |
|
|
39,484 |
|
| Provision for income taxes |
|
(14,082 |
) |
|
(8,473 |
) |
| Net income including controlling interest |
|
53,574 |
|
|
31,011 |
|
| Less: net (income) attributable to controlling interest |
|
(200 |
) |
|
(110 |
) |
| Net income attributable to Dolby Laboratories, Inc. |
|
$ |
53,374 |
|
|
$ |
30,901 |
|
|
|
|
|
|
| Net income per share: |
|
|
|
|
| Basic |
|
$ |
0.53 |
|
|
$ |
0.31 |
|
| Diluted |
|
$ |
0.51 |
|
|
$ |
0.30 |
|
| Weighted-average shares outstanding: |
|
|
|
|
| Basic |
|
101,483 |
|
|
100,734 |
|
| Diluted |
|
103,876 |
|
|
101,931 |
|
|
|
|
|
|
|
DOLBY LABORATORIES, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)
|
|
|
|
|
|
|
|
December 30,
2016 |
|
September 30,
2016 |
| ASSETS |
|
(unaudited) |
|
|
| Current assets: |
|
|
|
|
| Cash and cash equivalents |
|
$ |
512,838 |
|
|
$ |
516,112 |
|
| Restricted cash |
|
5,075 |
|
|
3,645 |
|
| Short-term investments |
|
164,818 |
|
|
121,629 |
|
| Accounts receivable |
|
81,393 |
|
|
75,688 |
|
| Inventories |
|
14,773 |
|
|
16,354 |
|
| Prepaid expenses and other current assets |
|
32,119 |
|
|
26,302 |
|
| Total current assets |
|
811,016 |
|
|
759,730 |
|
| Long-term investments |
|
350,360 |
|
|
393,904 |
|
| Property, plant and equipment, net |
|
459,709 |
|
|
443,656 |
|
| Intangible assets, net |
|
206,862 |
|
|
215,342 |
|
| Goodwill |
|
307,121 |
|
|
309,616 |
|
| Deferred taxes |
|
171,388 |
|
|
166,790 |
|
| Other non-current assets |
|
24,247 |
|
|
21,068 |
|
| Total assets |
|
$ |
2,330,703 |
|
|
$ |
2,310,106 |
|
|
|
|
|
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
| Current liabilities: |
|
|
|
|
| Accounts payable |
|
$ |
11,541 |
|
|
$ |
17,544 |
|
| Accrued liabilities |
|
169,711 |
|
|
169,055 |
|
| Income taxes payable |
|
1,514 |
|
|
2,304 |
|
| Deferred revenue |
|
24,405 |
|
|
24,180 |
|
| Total current liabilities |
|
207,171 |
|
|
213,083 |
|
| Long-term deferred revenue |
|
34,603 |
|
|
35,366 |
|
| Other non-current liabilities |
|
88,271 |
|
|
82,922 |
|
| Total liabilities |
|
330,045 |
|
|
331,371 |
|
|
|
|
|
|
| Stockholders’ equity: |
|
|
|
|
| Class A common stock |
|
56 |
|
|
57 |
|
| Class B common stock |
|
44 |
|
|
44 |
|
| Additional paid-in capital |
|
36,435 |
|
|
42,032 |
|
| Retained earnings |
|
1,977,478 |
|
|
1,938,320 |
|
| Accumulated other comprehensive (loss) |
|
(19,679 |
) |
|
(10,197 |
) |
| Total stockholders’ equity – Dolby Laboratories, Inc. |
|
1,994,334 |
|
|
1,970,256 |
|
| Controlling interest |
|
6,324 |
|
|
8,479 |
|
| Total stockholders’ equity |
|
2,000,658 |
|
|
1,978,735 |
|
| Total liabilities and stockholders’ equity |
|
$ |
2,330,703 |
|
|
$ |
2,310,106 |
|
|
|
|
|
DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
|
|
|
|
|
|
Fiscal Quarter Ended |
|
|
December 30,
2016 |
|
January 1,
2016 |
| Operating activities: |
|
(unaudited) |
|
(unaudited) |
| Net income including controlling interest |
|
$ |
53,574 |
|
|
$ |
31,011 |
|
| Adjustments to reconcile net income to net cash provided by operating
activities: |
|
|
|
|
| Depreciation and amortization |
|
21,810 |
|
|
21,814 |
|
| Stock-based compensation |
|
17,215 |
|
|
19,380 |
|
| Amortization of premium on investments |
|
662 |
|
|
1,605 |
|
| Excess tax benefit from exercise of stock options |
|
(2,962 |
) |
|
(300 |
) |
| Provision for doubtful accounts |
|
67 |
|
|
(322 |
) |
| Deferred income taxes |
|
(3,275 |
) |
|
(10,488 |
) |
| Other non-cash items affecting net income |
|
(376 |
) |
|
445 |
|
| Changes in operating assets and liabilities: |
|
|
|
|
| Accounts receivable |
|
(5,782 |
) |
|
11,961 |
|
| Inventories |
|
878 |
|
|
(877 |
) |
| Prepaid expenses and other assets |
|
(8,705 |
) |
|
(3,567 |
) |
| Accounts payable and other liabilities |
|
(11,528 |
) |
|
(14,574 |
) |
| Income taxes, net |
|
6,245 |
|
|
5,014 |
|
| Deferred revenue |
|
(479 |
) |
|
6,319 |
|
| Other non-current liabilities |
|
417 |
|
|
(26 |
) |
| Net cash provided by operating activities |
|
67,761 |
|
|
67,395 |
|
|
|
|
|
|
| Investing activities: |
|
|
|
|
| Purchase of investments |
|
(37,073 |
) |
|
(85,299 |
) |
| Proceeds from sales of investment securities |
|
7,524 |
|
|
121,770 |
|
| Proceeds from maturities of investment securities |
|
26,902 |
|
|
14,610 |
|
| Purchases of PP&E |
|
(22,576 |
) |
|
(24,368 |
) |
| Purchase of intangible assets |
|
— |
|
|
(105,270 |
) |
| Change in restricted cash |
|
(1,430 |
) |
|
(1,395 |
) |
| Net cash used in investing activities |
|
(26,653 |
) |
|
(79,952 |
) |
|
|
|
|
|
| Financing activities: |
|
|
|
|
| Proceeds from issuance of common stock |
|
13,991 |
|
|
9,986 |
|
| Repurchase of common stock |
|
(25,001 |
) |
|
(39,449 |
) |
| Payment of cash dividend |
|
(14,216 |
) |
|
(12,114 |
) |
| Distribution to controlling interest |
|
(2,094 |
) |
|
(214 |
) |
| Excess tax benefit from exercise of stock options |
|
2,962 |
|
|
300 |
|
| Shares repurchased for tax withholdings on vesting of restricted stock |
|
(14,656 |
) |
|
(9,839 |
) |
| Net cash used in financing activities |
|
(39,014 |
) |
|
(51,330 |
) |
|
|
|
|
|
| Effect of foreign exchange rate changes on cash and cash equivalents |
|
(5,368 |
) |
|
(940 |
) |
| Net decrease in cash and cash equivalents |
|
(3,274 |
) |
|
(64,827 |
) |
| Cash and cash equivalents at beginning of period |
|
516,112 |
|
|
531,926 |
|
| Cash and cash equivalents at end of period |
|
$ |
512,838 |
|
|
$ |
467,099 |
|
| |
GAAP to Non-GAAP Reconciliations
(in millions, except per share data) |
|
|
|
|
|
| The following tables present Dolby's GAAP financial measures reconciled
to the non-GAAP financial measures included in this release for the first quarter of fiscal 2017 and 2016: |
|
|
|
|
|
| Net income: |
|
Fiscal Quarter Ended |
|
|
December 30,
2016 |
|
January 1,
2016 |
| GAAP net income |
|
$ |
53.4
|
|
$ |
30.9
|
| Stock-based compensation |
|
17.2
|
|
19.4
|
| RSU dividend equivalent |
|
0.2
|
|
0.4
|
|
Amortization of acquisition-related intangibles
|
|
3.8
|
|
4.1
|
| Income tax adjustments |
|
(5.9) |
|
(6.2) |
| Non-GAAP net income |
|
$ |
68.7
|
|
$ |
48.6
|
|
|
|
|
|
| Diluted earnings per share: |
|
Fiscal Quarter Ended |
|
|
December 30,
2016 |
|
January 1,
2016 |
| GAAP diluted earnings per share |
|
$ |
0.51
|
|
$ |
0.30
|
| Stock-based compensation |
|
0.17
|
|
0.19
|
| RSU dividend equivalent |
|
—
|
|
0.01
|
|
Amortization of acquisition-related intangibles
|
|
0.04
|
|
0.04
|
| Income tax adjustments |
|
(0.06) |
|
(0.06) |
| Non-GAAP diluted earnings per share |
|
$ |
0.66
|
|
$ |
0.48
|
|
|
|
|
|
| Shares used in computing diluted earnings per share |
|
104
|
|
102
|
|
|
|
|
|
| The following tables present a reconciliation between GAAP and non-GAAP
versions of the estimated financial amounts for the second quarter of fiscal 2017 and fiscal year 2017 included in this
release: |
|
|
|
|
|
| Gross margin: |
|
Q2 2017 |
|
|
| GAAP gross margin (low - high end of range) |
|
88% - 89% |
|
|
| Stock-based compensation |
|
0.1% |
|
|
|
Amortization of acquisition-related intangibles
|
|
0.9% |
|
|
| Non-GAAP gross margin (low - high end of range) |
|
89% - 90% |
|
|
|
|
|
|
|
| Operating expenses: |
|
Q2 2017 |
|
Fiscal 2017 |
| GAAP operating expenses (low - high end of range) |
|
$177 - $181 |
|
$700 - $710 |
| Stock-based compensation |
|
(18.0) |
|
(70.0) |
|
Amortization of acquisition-related intangibles
|
|
(1.0) |
|
(5.0) |
| Non-GAAP operating expenses (low - high end of range) |
|
$158 - $162 |
|
$625 - $635 |
|
|
|
|
|
| Diluted earnings per share: |
|
Q2 2017 |
|
|
Low |
|
High |
| GAAP diluted earnings per share |
|
$ |
0.43
|
|
$ |
0.49
|
| Stock-based compensation |
|
0.17
|
|
0.17
|
|
Amortization of acquisition-related intangibles
|
|
0.03
|
|
0.03
|
| Income tax adjustments |
|
(0.05) |
|
(0.05) |
| Non-GAAP diluted earnings per share |
|
$ |
0.58
|
|
$ |
0.64
|
|
|
|
|
|
| Shares used in computing diluted earnings per share |
|
104
|
|
104
|
Dolby Laboratories
Investor Contact:
Elena Carr, 415-645-5583
investor@dolby.com
or
Media Contact:
Joy Nestor, 415-558-0164
joy.nestor@dolby.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170125005938/en/